Rare Diseases (@CheckOrphan) header
Rare Diseases (@CheckOrphan) profile picture

CheckOrphan is the leading #news and information platform dedicated to #rarediseases and #orphandrugs

Santa Cruz, USA / Basel, CH
Joined April 2009
Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)Photo by Rare Diseases (@CheckOrphan)
Novartis Receives Positive CHMP Opinion for Cosentyx® in Adolescents aged 12+ with Hidradenitis Suppurativa (HS) - For More Information Visit tinyurl.com/4p5twcjc @Novartis #CHMP #Rare_Diseases #Orphan_Drugs #Cosentyx #Hidradenitis_Suppurativa #Drug_Research
1
148
CHMP Recommends EU Approval of Roche’s Gazyva/Gazyvaro for Systemic Lupus Erythematosus (SLE) - For More Information Visit tinyurl.com/mr2b4zva @Roche #SLE #Systemic_Lupus_Erythematosus #CHMP #Rare_Diseases #Orphan_Drugs #Gazyva
3
2
242
Novo Submits Etavopivat, an Investigational Once-Daily Therapy for Adolescents and Adults Living with Sickle Cell Disease, to The FDA and EMA For Approval - For More Information Visit tinyurl.com/m64a6dcd @novonordiskus #FDA #EMA #Sickle_Cell_Disease #Rare_Diseases
3
173
Ionis Reports New Two-Year Data Showing Sustained 95% Reduction in Hereditary Angioedema Attacks with DAWNZERA at ACAAI 2026 Annual Meeting - For More Information Visit tinyurl.com/mtb4uesb @ionispharma #HAE #Hereditary_Angioedema #Rare_Diseases #Orphan_Drugs
1
148
Bexsero ( 4CMenB ) receives positive CHMP opinion for one-dose Meningitis B booster for 10+ year olds - For More Information Visit tinyurl.com/3edvvdrv @gskca #Meningitis_B #Meningitis #Rare_Diseases #CHMP
131
Can-Fite's Piclidenoson Shows Up to 80% Kidney Disease Marker Improvement in Lowe Syndrome Preclinical Study Published in Nature Portfolio Journal - For More Information Visit tinyurl.com/2yxk8f2c @CanFitePharma #Lowe_Syndrome #Rare_Diseases #Orphan_Drugs
116
Palleon Pharmaceuticals Presents Phase 2 Results for HLX79/E-602 in Primary Membranous Nephropathy at ACR Convergence 2026 - For More Information Visit tinyurl.com/dkxpfw7m @Palleon_Pharma #Orphan_Drugs #pMN #Rare_Diseases #Primary_Membranous_Nephropathy
2
3
205
Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® in Squamous Cell Anal Carcinoma - For More Information Visit tinyurl.com/mr49skkj @Oncolytics #SCAC #Anal_Cancer #Rare_Diseases #Orphan_Drugs
97
Enhertu® Supplemental New Drug Application Submitted in Japan for Patients with HER2 Expressing Advanced or Recurrent Uterine Carcinosarcoma - For More Information Visit tinyurl.com/ku4taepr #UCS #Rare_Diseases @DaiichiSankyo #Uterine_Carcinosarcoma
88
Novartis Reports Sustained Long-Term Efficacy and Safety of Ianalumab for Sjögren’s Disease Based on NEPTUNUS Extension Study Results - For More Information Visit tinyurl.com/8fnvwbbs @Novartis #Sjögren_Syndrome #Ianalumab #Rare_Diseases #Orphan_Drugs
1
138
Larimar Therapeutics Completes Rolling BLA Submission Seeking Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia - For More Information Visit tinyurl.com/3bzjyzvx #Friedreich_Ataxia #FA @larimarthrx #Rare_Diseases #Orphan_Drugs #Larimar #FDA
143
Monopar Presents Phase 3 FoCus Trial Data Highlighting Residual Disease Burden in Wilson Disease and Long-Term ALXN1840 Safety - For More Information Visit tinyurl.com/y4zjherb @MonoparTx #Wilson_Disease #Rare_Diseases #Orphan_Drugs #ALXN1840
121
Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia - For More Information Visit tinyurl.com/5fdybnjz @Hemab_Tx #Glanzmann_Thrombasthenia #Rare_Diseases #Orphan_Drugs #Sutacimig #Drug_research
108
argenx Presents Phase 3 ALKIVIA Data at ACR Convergence 2026 Showing Rapid and Sustained Improvement with Efgartigimod in Autoimmune Myositis - For More Information Visit tinyurl.com/h3tsfc @argenxglobal #Autoimmune_Myositis #Rare_Diseases #Orphan_Drugs #Efgartigimod
1
2
305
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K. - For More Information Visit tinyurl.com/zj75k4r3 #MHRA @PharmingGroupNV #APDS #Rare_Diseases #Orphan_Drugs #Activated_PI3K_Delta_Syndrome
1
140
Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO™ as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer - For More Information Visit tinyurl.com/5crkcx4v @JNJInnovMed #Head_and_Neck_Cancer #FDA #RYBREVANT_FASPRO #Rare_Diseases
1
125
Satellos Selects MRI-Measured Muscle Fat Fraction as Primary Endpoint in Phase 2 Duchenne Muscular Dystrophy Trial Following FDA Feedback - For More Information Visit tinyurl.com/4mwywubn @SatellosBio #Duchenne #DMD #Muscular_Dystrophy #Rare_Diseases #Orphan_Drugs
1
2
347
Gilead’s Livdelzi Achieves ALP Normalization in 75.4% of Primary Biliary Cholangitis (PBC) Patients in Phase 3 IDEAL Study - For More Information Visit tinyurl.com/ycx55css @GileadSciences #Primary_Biliary_Cholangitis #PBC #Rare_Diseases #Orphan_Drugs
1
133
Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome - For More Information Visit tinyurl.com/53kbd2tw @RhythmPharma #BBS #Bardet_Biedl_Syndrome #IMCIVREE #Rare_Diseases #Orphan_Drugs
1
2
207
Pasithea Therapeutics Announces FDA Clearance of IND for PAS-004 in Neurofibromatosis Type 1 (NF1)-Associated Cutaneous Neurofibromas - For More Information Visit tinyurl.com/25t8wsay #Pasithea #FDA #NF1 #Neurofibromatosis #Rare_Diseases #Orphan_Drugs
189